发明名称 ADMINISTRATION OF DENDRITIC CELL PARTIALLY MATURED IN VITRO FOR TREATMENT OF TUMOR
摘要 <P>PROBLEM TO BE SOLVED: To provide efficient up take and processing of tumor antigen within a tumor and tumor bed in spite of overall immunosuppressive environment within the tumor. <P>SOLUTION: There are provided populations of cells comprising partially matured dendritic cells that can be used for administration individuals having a tumor. Partially matured dendritic cells, those contacted with a dendritic cell maturation agent for about 1 to about 10 hours, or more, efficiently take up and process tumor antigens in the area of the tumor site, complete maturation, and can subsequently migrate to the lymph nodes of a treated individual. Once in the lymph node, the now fully mature antigen presenting dendritic cells secrete the appropriate cytokines (e.g., TNFalpha and IL-12) and contact T cells inducing a substantial anti-tumor immune response. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2011246493(A) 申请公布日期 2011.12.08
申请号 JP20110196385 申请日期 2011.09.08
申请人 NORTHWEST BIOTHERAPEUTICS INC 发明人 BOSCH MARNIX L
分类号 A61K35/26;A61K35/14;A61K39/00;A61K47/22;A61K47/42;A61P35/00;A61P37/04;C12N5/0784 主分类号 A61K35/26
代理机构 代理人
主权项
地址